|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 1/113 | |
| C07K 16/18 | |||
| A61K 39/395 | |||
| C07K 16/28 |
| (11) | Number of the document | 3286204 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16719824.1 |
| Date of filing the European patent application | 2016-04-22 | |
| (97) | Date of publication of the European application | 2018-02-28 |
| (45) | Date of publication and mention of the grant of the patent | 2020-11-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2016/059051 |
| Date | 2016-04-22 |
| (87) | Number | WO 2016/170138 |
| Date | 2016-10-27 |
| (30) | Number | Date | Country code |
| 201506870 | 2015-04-22 | GB |
| (72) |
HEYWOOD, Sam Philip, GB
WILD, Gavin Barry, GB
HANIF, Razwan, GB
LE PAGE, Christopher John, GB
|
| (73) |
UCB Biopharma SRL,
Allée de la Recherche 60, 1070 Brussels,
BE
|
| (54) | METHOD OF MONOMERISATION OF RECOMBINANT ANTIBODY MOLECULES |
| METHOD OF MONOMERISATION OF RECOMBINANT ANTIBODY MOLECULES |